Industry Symposium 16

13:30-15:00 Capital Suite 2-3-4

Steps Forward: Fabry Disease in Nephrology

Chair: Alberto Ortiz, Madrid, Spain

Occurence Of Severe Clinical Events by time On Agalsidase Beta among Patients with Fabry Disease
Alberto Ortiz, Madrid, Spain
FAbry STabilization indEX (FASTEX)
Renzo Mignani, Rimini, Italy
Ten-year outcome of Enzyme Replacement Therapy with Agalsidase Beta in Patients with Fabry Disease
Dominique P. Germain, Paris, France

Organised by GENZYME


back to the timetable